- Supported exchanges /
- NASDAQ /
- LENZ.NASDAQ
LENZ Therapeutics Inc (LENZ NASDAQ) stock market data APIs
$27
-0.93(-3.3%)
as of November 1, 2024
Price chart is built with Anychart
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
LENZ Therapeutics Inc Financial Data Overview
27.93 | |
27 | |
- | |
28.58 | |
26.12 | |
1.3589-31 | |
600 M | |
27 470 K | |
0 | |
-0.4 | |
0 | |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'LENZ',
Type:
'Common Stock',
Name:
'LENZ Therapeutics Inc',
Exchange:
'NASDAQ',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG00XDH4NZ2',
ISIN:
NULL,
CUSIP:
NULL,
CIK:
'1815776',
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
'2021-06-25',
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
HomeCategory:
NULL,
IsDelisted:
false,
}
LENZ Therapeutics Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -75 263 000
- Earnings Per Share -2.74
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get LENZ Therapeutics Inc Earnings via APIs
- Latest Release 2024-08-15
- EPS/Forecast -0.49
Get LENZ Therapeutics Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: